Cargando…

Reply: The value of case–control audits of screening

Detalles Bibliográficos
Autores principales:	Sasieni, P, Adams, J, Cuzick, J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409620/ http://dx.doi.org/10.1038/sj.bjc.6601599

Ejemplares similares

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories
por: Sasieni, P, et al.
Publicado: (2003)

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group.
por: Sasieni, P. D., et al.
Publicado: (1996)

Reply to ‘Comment on Cancer incidence in the United Kingdom: projections to the year 2030'
por: Ahmad, A S, et al.
Publicado: (2013)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Auditing the value of empirical audits
por: Lynch, John G., et al.
Publicado: (2023)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Reply: Selection of controls
por: Dalton, S O, et al.
Publicado: (2007)

Reply
por: Lokken, Erica M., et al.
Publicado: (2020)

Reply: Screening for colorectal cancer with immunological FOBT
por: Saito, Hiroshi, et al.
Publicado: (2004)

Reply: Flawed methods explain the effect of mammography screening in Nijmegen
por: Verbeek, A L M, et al.
Publicado: (2011)

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments
por: Evans, Nicholas Greig
Publicado: (2014)

Reply: Value of tyrosinase RT–PCR in melanoma prognosis
por: Gogas, H
Publicado: (2003)

Organisation of Clinical Audit
por: Hancock, R J T
Publicado: (1997)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Screening Blood Donors at Risk for Malaria: Reply to Hänscheid et al.
por: Benito, A., et al.
Publicado: (2002)

Cost-Effective Screening for Trichomoniasis—reply to Dr. Schwebke
por: Sorvillo, Frank, et al.
Publicado: (2002)

Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
por: Oei, A L M, et al.
Publicado: (2006)

Distribution of breast cancer risk from SNPs and classical risk factors in women of routine screening age in the UK
por: Brentnall, A R, et al.
Publicado: (2014)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Reply
por: Hirsova, Petra, et al.
Publicado: (2015)

Reply
por: Rasmussen, Sonja A., et al.
Publicado: (2020)

Reply: Estimation of lead-time and overdiagnosis in breast cancer screening
por: Duffy, S W, et al.
Publicado: (2009)

Reply: benefits of screening cancer patients for distress still not demonstrated
por: Carlson, L E, et al.
Publicado: (2013)

Reply to: Balancing Cost and Efficiency in Screening Potential Organ Donors With Whole Body CT
por: Mensink, Jacobus W., et al.
Publicado: (2020)

Reply
por: Villaverde, Serena, et al.
Publicado: (2021)

Reply
por: Berlana, David, et al.
Publicado: (2022)

Genetic landscape of prognostic value in pancreas ductal adenocarcinoma microenvironment—reply
por: Pu, Ning, et al.
Publicado: (2020)

Reply()
por: Barrios-López, J.M., et al.
Publicado: (2021)

REPLY
por: Kumar, P.N. Suresh
Publicado: (1999)

Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma – a reply
por: Guerry, M, et al.
Publicado: (2000)

Reply
por: Jain, Sanjeev, et al.
Publicado: (1986)

Reply
por: Forrer, F., et al.
Publicado: (2007)

Medical Audit of Case Notes on One to One Basis
por: Rai, G. S., et al.
Publicado: (1991)

Resuscitation Decisions: Audit
por: Griffith, David, et al.
Publicado: (1999)

In reply to: “A COVID-19 screening tool for oncology telephone triage”
por: Lasagna, Angioletta, et al.
Publicado: (2020)

In Reply
por: Brennen, W. Nathaniel, et al.
Publicado: (2019)

In Reply
por: Coomes, Eric A., et al.
Publicado: (2020)

Prognostic value of circulating chromogranin A levels in acute coronary syndrome: reply
por: Røsjø, Helge, et al.
Publicado: (2010)

Is the Diagnostic Value of Electrocardiography for the Measurement of Left Ventricular Mass Index Underestimated? Reply
por: Noori, Noor Mohammad, et al.
Publicado: (2014)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_caresu36kr019g2cpl5tgt80ea